Inovio Pharmaceuticals (INO) Other Accumulated Expenses (2018 - 2026)
Inovio Pharmaceuticals (INO) posted Other Accumulated Expenses of $338,461 for Q2 2026, down 77.6% from $1.51 million a year earlier and down 58.6% from the prior quarter.
Powered by 
Analysis
Inovio Pharmaceuticals (INO) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, Inovio Pharmaceuticals' Other Accumulated Expenses came in at $650,680, down 67.8% from FY2024.
- Annual Other Accumulated Expenses has declined for three consecutive years, with a five-year compound annual growth rate of -42.0% (FY2020 to FY2025).
- In prior years, Inovio Pharmaceuticals' Other Accumulated Expenses was $2.02 million in FY2024 (-14.5%), $2.37 million in FY2023 (-77.7%), $10.59 million in FY2022 (+2.6%) and $10.33 million in FY2021 (+3.8%).
- The Q2 2026 figure stands as the lowest quarterly Other Accumulated Expenses since Q1 2018.
- On a year-over-year basis, Other Accumulated Expenses has declined in each of the last 14 quarters, with an average decline of 52.0% over the last eight quarters.
- The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q3 2021, with growth of 133.2%; the weakest was Q3 2025, with a decline of 78.7%.
- According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $817,331 (Q1 2026), $650,680 (Q4 2025) and $955,970 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Inovio Pharmaceuticals | 94.68 Mn | 94.68 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 338,461.00 |
| Mar 31, 2026 | 817,331.00 |
| Dec 31, 2025 | 650,680.00 |
| Sep 30, 2025 | 955,970.00 |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.82 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 5.50 Mn |
| Mar 31, 2024 | 3.02 Mn |
| Dec 31, 2023 | 2.37 Mn |
| Sep 30, 2023 | 5.01 Mn |
| Jun 30, 2023 | 6.17 Mn |
| Mar 31, 2023 | 5.80 Mn |
| Dec 31, 2022 | 10.59 Mn |
| Sep 30, 2022 | 13.49 Mn |
| Jun 30, 2022 | 10.12 Mn |
| Mar 31, 2022 | 11.83 Mn |
| Dec 31, 2021 | 10.33 Mn |
| Sep 30, 2021 | 13.62 Mn |
API Access
Inovio Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();